Blueblood Ventures Board Meeting for Q2 FY27 Results

Addressee: The Secretary, BSE Limited, Phiroze Jeejeebhoy Tower, 25th Floor, Dalal Street, Mumbai-400001

Meeting Date: Friday, November 13th, 2026
Location: M-55, Third Floor, Greater Kailash-II, New Delhi-110048
Primary Agenda: To consider and approve the Unaudited Standalone Financial Results for the Second Quarter and half year ended September 30, 2026

Trading Window Closure: Effective from September 30, 2026
Trading Window Reopening: November 15th, 2026
Applicable To: All Designated Persons including Insiders
Regulatory Basis: SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's "Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities by Designated Persons"
Previous Intimation: Reference made to an earlier intimation regarding the trading window closure

Financial impact not quantified in the disclosure. The meeting is for consideration and approval of financial results.